As of 2022, non-Hispanic white people in the United States had the highest incidence rates of skin cancer among all races and ethnicities. Skin cancer is one of the most commonly occurring cancers in the world. Furthermore, the United States is among the countries with the highest rates of skin cancer worldwide. Skin cancer in the U.S. There are a few different types of skin cancer, and some are more deadly than others. Basal and squamous skin cancers are more common and less dangerous than melanomas. Among U.S. residents, skin cancer has been demonstrated to be more prevalent among men than women. Skin cancer is also more prevalent among older adults. With treatment and early detection, skin cancers have a high survival rate. Fortunately, in recent years the U.S. has seen a reduction in the rate of death from melanoma. Skin cancer prevention Avoiding and protecting exposed skin from the sun (and other sources of UV light) is the primary means of preventing skin cancer. However, a survey of U.S. adults from 2024 found that around ******* never used sunscreen.

Between the years 2012 and 2016, there were 372 invasive melanoma cases recorded in the Black population in the U.S. versus 1,725 such cases for Hispanics. The statistic illustrates the number of invasive melanoma cases in the U.S. between 2012 and 2016, by race/ethnicity.

From 2012 to 2016, around ****** cases of invasive melanoma were recorded among males in the U.S. from all races, with around ****** cases among White, Non-Hispanic males. The statistic illustrates the number of invasive melanoma cases in U.S. males between 2012 and 2016, by race/ethnicity.

From 2012 to 2016, there were around ** annual deaths from invasive melanoma among Hispanic females. The statistic illustrates the average annual number of female deaths attributed to invasive melanoma in the U.S. between 2012 and 2016, by race/ethnicity.

From 2012 to 2016, around ****** cases of invasive melanoma were recorded among females in the U.S. from all races.The statistic illustrates the number of invasive melanoma cases in U.S. females between 2012 and 2016, by race/ethnicity.

This dataset provides detailed information on global cancer incidence rates and numbers for both males and females in the year 2022. It includes data on various types of cancer, both including and excluding non-melanoma skin cancer (NMSC). The dataset is organized into two CSV files:

Global cancer incidence in males and females (2022).csv: Contains detailed data for individual countries, including cancer incidence rates and numbers for both males and females, categorized by including and excluding NMSC. Overall global cancer incidence (2022).csv: Provides an aggregated view of global cancer incidence, summarizing key statistics across different regions and demographics.

From 2012 to 2016, there were around 140 annual deaths among Hispanic males in the U.S. due to invasive melanoma. The statistic illustrates the average annual number of male deaths attributed to invasive melanoma in the U.S. between 2012 and 2016, by race/ethnicity.

BackgroundMelanoma incidence is rising globally, yet epidemiological data from Latin America remain limited. In low- and middle-income countries, such data are essential for shaping evidence-based public health strategies. ObjectivesTo describe the demographic, clinical, and pathological characteristics of melanoma in Chile using a multi-institutional registry.MethodsWe conducted a multicenter observational cohort study including patients ≥18 years with histologically confirmed melanoma diagnosed between 2014 and 2022 at one public and one private tertiary center in Santiago. Demographic, clinical, pathological, molecular, and survival data for cutaneous melanoma were analyzed using descriptive and survival statistics.ResultsA total of 1,037 patients were included, of whom 979 (94.4%) had cutaneous melanoma. Among these patients, median age was 55 years and 54.8% were female. Cutaneous melanoma was more often diagnosed at early stages, particularly in the private setting. The most frequent histopathological subtypes were superficial spreading (31.6%), nodular (17.8%), and acral lentiginous melanoma (9.3%). Self-detection was the most common mode of identification (52.8%). Among patients with stage III–IV cutaneous melanoma tested for BRAF, 47.6% were positive. Higher risk of death was associated with advanced stage, nodular or amelanotic subtypes, BRAF-mutant tumors, male sex, and age ≥65 years. Only 34.8% of patients with stage IIB–IV cutaneous melanoma received systemic therapy.ConclusionThis study offers the most comprehensive characterization of melanoma in Chile to date, underscoring survival disparities by clinical, pathological, and healthcare access factors. Findings highlight the urgent need to expand access to early detection, molecular testing, and systemic therapies.

[Notes: *Statistically significant difference (p = 0.005) between positive serology group (n = 47) and clinical criteria only group (n = 124) with respect to the patient characteristic (Chi-square test)].

Data by medical encounter for the following conditions by age, race/ethnicity, and gender:

Acute Myocardial Infarction (AMI)
Asthma
Bladder Cancer
Brain Cancer
Coronary Heart Disease (CHD)
Colorectal Cancer
Chronic Obstructive Pulmonary Disease (COPD)/Chronic Lower Respiratory Diseases
Diabetes
Female Breast Cancer
Female Reproductive Cancer
Heart Failure
Hyperlipidemia (High Blood Cholesterol)
Kidney Cancer
Leukemia
Liver Cancer Lung Cancer Lupus and Connective Tissue Disorders
Melanoma of the Skin
Non-Hodgkin's Lymphoma
Non-melanoma Skin Cancer
Overall Cancer
Overall Heart Disease
Overall Hypertensive Diseases
Pancreatic Cancer
Prostate Cancer Stroke
Thyroid Cancer

Rates per 100,000 population. Age-adjusted rates per 100,000 2000 US standard population.
Blank Cells: Rates not calculated for fewer than 11 events. Rates not calculated in cases where zip code is unknown. Geography not reported where there are no cases reported in a given year. SES: Is the median household income by SRA community. Data for SRAs only.
*The COVID-19 pandemic was associated with increases in all-cause mortality. COVID-19 deaths have affected the patterns of mortality including those of Non-Communicable conditions.

Data sources: California Department of Public Health, Center for Health Statistics, Office of Health Information and Research, Vital Records Business Intelligence System (VRBIS). California Department of Health Care Access and Information (HCAI), Emergency Department Database and Patient Discharge Database, 2020. SANDAG Population Estimates, 2020 (vintage: 09/2022). Population estimates were derived using the 2010 Census and data should be considered preliminary. Prepared by: County of San Diego, Health and Human Services Agency, Public Health Services, Community Health Statistics Unit, February 2023.

The incidence of cutaneous melanoma has been increasing in the last decades among fair-skinned population. Despite complex and multifactorial etiology, the exposure to ultraviolet radiation (UVR) is the most consistent modifiable risk factor for melanoma. Several factors influence the amount of UVR reaching Earth’s surface. Our study aimed to explore the relationship between melanoma and altitude in an area with mixed geographic morphology, such as the Veneto region (Italy). We included 2,752 melanoma patients who were referred to our centers between 1998 and 2014. Demographics, histological and clinical data, and survival information were extracted from a prospectively maintained local database. Head/neck and acral melanoma were more common in patients from the hills and the mountains, while limb and trunk melanoma were more common in patients living in plain and coastal areas. Breslow thickness, ulceration and mitotic rate impaired with increased altitude. However, geographical area of origin was not associated with overall or disease-free survival. Geographical area of origin of melanoma patients and the “coast-plain-hill gradient” could help to estimate the influence of different sun exposure and to explain the importance of vitamin D level in skin-cancer control .

In 2022, Australia had the fourth-highest total number of skin cancer cases worldwide and the highest age-standardized rate, with roughly 37 cases of skin cancer per 100,000 population. The graph illustrates the rate of skin cancer in the countries with the highest skin cancer rates worldwide in 2022.

Background: Tattooing is an increasingly prevalent practice that is associated with various clinical complications. The carcinogenic potential of tattoo pigments remains unclear. While 45 case reports have described melanomas colocalizing with tattoos thus far, a pathogenetic link between tattoos and melanomas remains unproven. No nationwide epidemiological study has investigated the incidence of tattoo-associated melanoma (TAM).

Objectives: To determine the incidence of TAM in the Netherlands from 1991 to 2023, analyse TAM characteristics and patient demographics, and compare these findings with melanoma data from the general Dutch population during the same period.

Methods: Data were obtained from the nationwide network and registry of histo- and cytopathology in the Netherlands (PALGA). Malignant and benign melanocytic lesions on the tattooed skin were included. Patient demographics and melanoma characteristics were extracted and analysed. Data from the Netherlands Cancer Registry were used for comparison.

Results: From 1991 to 2023, 94 TAMs and 467 benign melanocytic lesions on tattoos were identified. The annual incidence of TAMs has increased over time. TAMs were diagnosed at an overall median age of 48.0 years, predominantly in males (64.9%). The median Breslow thickness was 0.9 mm, and most TAMs were TNM stage I (76.6%). The number-needed-to-excise was 6.0.

Discussion: 94 unique TAMs were identified in the Netherlands, which makes the largest case series to date. However, TAM incidence remained low (0.07%) compared to the total melanoma incidence, indicating that tattoos likely do not increase the risk of melanoma. A diagnostic delay from obscuring was considered unlikely based on the presented findings.

Conclusion: This nationwide cohort study found no evidence supporting a causal relationship between tattoos and melanoma.